A5043821337- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Aortic Disease and Treatment Approaches
- Cardiovascular Function and Risk Factors
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
Université Laval
2018-2023
Lung Institute
2020
Montreal Heart Institute
2019
Instituto Dante Pazzanese de Cardiologia
2018
Background: Currently, 2 third-generation transcatheter valves, 29-mm Sapien-3 and 34-mm Evolut-R (ER), are indicated for large sized aortic annuli. We analyzed short 1-year performance of these valves in patients with (area ≥575 mm or perimeter ≥85 mm) extra-large (≥683 ≥94.2 annuli undergoing valve replacement. Methods: A total 833 across 12 centers symptomatic stenosis underwent replacement (n=640) ER (n=193). Clinical, anatomic, procedural characteristics were collected, Valve Academic...
Abstract Background Conduction disturbances are the most frequent complication of transcatheter aortic valve replacement (TAVR). However, no data exists regarding outcomes intraprocedural high‐degree atrioventricular block (HAVB) or complete heart (CHB) in patients without previous conduction disturbances. Objectives The aim this study was to evaluate intraprocedural‐HAVB/CHB intraventricular Methods occurrence assessed 676 consecutive undergoing TAVR, and two groups were established...
To report on the feasibility and technical differences between coronary procedures performed before after TAVR with balloon-expandable Edwards-SAPIEN or SAPIEN XT valves.Coronary artery disease (CAD) aortic stenosis often coexist. Transcatheter valve replacement (TAVR) is emerging as a treatment for younger lower surgical risk patients who might not present clinically evident CAD TAVR. The demand performing post-TAVR angiograms (CAs) percutaneous interventions (PCIs) will thus increase,...
Many patients referred for a MitraClip intervention are finally refused this intervention, and data very scarce on their outcomes. Our study sought to determine the characteristics outcomes of who mitral valve clinic denied from percutaneous edge-to-edge repair.
To enlighten preprocedural risk factors of mitral valve restenosis in a large, single-center cohort patients submitted to percutaneous balloon commissurotomy (PMBC) for the treatment stenosis (MS) secondary rheumatic heart disease.